Please visit answersincme.com/860/240201373-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Julie Stakiw, MD, FRCPC; and Constantine S. Tam, MBBS, MD. In this activity, experts in chronic lymphocytic leukemia (CLL) use case examples to discuss treatment management of high-risk CLL in both the frontline and relapsed/refractory settings. Upon completion of this activity, participants should be better able to: Identify high-risk chronic lymphocytic leukemia (CLL) based on cytogenetic, genomic, and clinical risk factors; Evaluate the latest clinical evidence informing the use of treatments for high-risk CLL in the frontline and relapsed/refractory (R/R) settings; and Apply guideline-concordant, evidence-based strategies to appropriately select and sequence treatments for high-risk CLL in the frontline and R/R settings.
AI Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Guidance on Menopause-Related Vasomotor Symptom Management: A Focus on Neurokinin-Targeted Treatment Options
From Evidence to Practice: Where Do BCMA Bispecific Antibodies and Anti-CD38 mAb Combinations Fit Into Community Care for RRMM?
Evolving Care in B-ALL: From Questions to Answers on the Role of CD19 Bispecific T-Cell Engagers
Navigating Urologic Cancer Care Across the Map: Getting up to Speed on the Latest Systemic Therapies for Renal Cell Carcinoma and Advanced Urothelial Carcinoma
Free AI-powered recaps of CME in Minutes: Education in Oncology & Hematology and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.